-
Mashup Score: 3cDPP3 in Cardiogenic Shock: More than just a prognostic marker? - 2 month(s) ago
Dr. Singh, Godding and Kataria report no disclosures. Dr. Kochar reports the following disclosures: Prior funding and site PI – Duke Institute of Health Innovation (DIHI), Duke Clinical Research Institute (DCRI), Abiomed, Novartis, Duke University, LiveNova, Endovascular Engineering, Chiesi; Active Grant Funding – AHA Career Development Award, Shockwave Inc, and Rampart Inc, PCORI; Consultant fees/Honoraria – Abiomed, Faraday Pharmaceuticals.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 20
Despite dramatic advances in therapeutics for patients with heart failure, fewer trainees are applying to Advanced Heart Failure/Transplant Cardiology (AHFTC) fellowship programs.1 The reasons for this waning interest are likely multifactorial.2 The purpose of this study was to comprehensively review the literature from all medical and surgical specialties, focusing on motivating factors that guide advanced training selection, reasoning that there may be commonalities identified that are applicable to AHFTC fellowship.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 3 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 3 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Home | Society of Critical Care Cardiology - 3 month(s) ago
At SoCCC our mission is to improve the care and outcomes of critically ill patients with cardiovascular disease and to promote, uphold, and advance the discipline of Critical Care Cardiology through education, advocacy, scientific discovery, and collaboration
Source: www.soccc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 27TecSalud | Cardiogenic Shock & Heart Failure Symposium - 4 month(s) ago
Octubre 02 & 03 2024 CANCÚN, MÉXICO El Segundo Simposio Anual de Shock Cardiogénico e Insuficiencia Cardíaca es un evento de primer nivel liderado por TecSalud, centrado en los avances, desafíos y enfoques innovadores en el manejo del shock cardiogénico y la insuficiencia cardíaca aguda. El tema de este año Creando equipos de “shock” ¿Qué se necesita para implementar un equipo? El choque cardiogénico es un problema clínico complejo y con alta mortalidad. Se ha publicado que la creación de “shock teams”
Source: content.tecsalud.mxCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 30Booster Shots: 019 - GDMT w/ Dr. Davis pt. 1 (B-blockers, ARNI) - 11 month(s) ago
We talk to Cardiologist Dr. Jonathan Davis, Director of the Heart Failure program from San Francisco General about goal directed medical therapy in heart failure with reduced ejection fraction (HFrEF). This is part 1 of 2 parts which will cover an overview of GDMT medications, and dive into Beta-blockers and ARNIs. Part 2 to come out next week! | 00.34 – Introduction | | 01.55 – Consult Q: GDMT for HF | Heart failure outcomes | 05.20 – GDMT medication summary and overview | | 07.17 – Effect on blood pressure and relative risk reduction for each drug | | 10.59 – What order to start in | Hint: ALL AT ONCE… if you can | 11.53 – Beta-blockers | When not to start (new HF in VOL), and when to re/start (almost all other times) Tartrate vs Succinate: duration of action | 15.40 – ARNI (Sacubitril-Valsartan) | Potent natriuresis effect Balancing the orthostatics | 20.37 – Outro | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the inform
Source: sites.libsyn.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 17Submit Your Science | Houston Shock - 1 year(s) ago
The Houston Shock Symposium is one of the largest and most comprehensive shock conferences in the nation. Join us in the heart of Houston, TX to advance knowledge and expertise to save lives and reduce shock’s unacceptably high mortality rate.
Source: www.houstonshock.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 16Submit Your Science | Houston Shock - 1 year(s) ago
The Houston Shock Symposium is one of the largest and most comprehensive shock conferences in the nation. Join us in the heart of Houston, TX to advance knowledge and expertise to save lives and reduce shock’s unacceptably high mortality rate.
Source: www.houstonshock.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 26Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis - 1 year(s) ago
Consensus recommendations for cardiogenic shock (CS) advise transfer of patients in need of advanced options beyond the capability of ‘spoke’ centers to tertiary/ ‘hub’ centers with higher capabilities. However, outcomes associated with such transfers are largely unknown, beyond those reported in individual health networks.
Source: onlinejcf.comCategories: Cardiologists, Latest HeadlinesTweet-
🔥off the press - The #CSWG transfer analysis #SimPub ❤️🔥>50% of CS pts managed at high vol. CS centers were transferred from another 🏥 ❤️🔥Transfer pts had >>☠️ than pts admitted to hub 🏥 ❤️🔥Outcomes & predictors varied significantly b/w HF-CS vs AMI-CS. https://t.co/boMF9qAjvT https://t.co/TvOrQit8BA
-
Could cDPP3 prove to be more than just a prognostic marker in cardiogenic shock? @Ajar_Kochar @AvinainderSingh https://t.co/g6doeZ7NWs